Kristyn Masters
Concepts (340)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Calcinosis | 15 | 2022 | 235 | 4.900 |
Why?
| | Aortic Valve | 17 | 2022 | 351 | 4.550 |
Why?
| | Extracellular Matrix | 21 | 2025 | 528 | 3.410 |
Why?
| | Aortic Valve Stenosis | 7 | 2022 | 229 | 3.120 |
Why?
| | Tissue Engineering | 13 | 2021 | 423 | 3.060 |
Why?
| | Biocompatible Materials | 15 | 2018 | 425 | 2.210 |
Why?
| | Heart Valve Diseases | 7 | 2017 | 151 | 1.870 |
Why?
| | Hyaluronic Acid | 7 | 2013 | 225 | 1.760 |
Why?
| | Polyurethanes | 5 | 2013 | 38 | 1.730 |
Why?
| | Epidermal Growth Factor | 6 | 2016 | 177 | 1.670 |
Why?
| | Nylons | 8 | 2014 | 18 | 1.660 |
Why?
| | Keratinocytes | 6 | 2016 | 249 | 1.650 |
Why?
| | Cell Culture Techniques | 8 | 2019 | 363 | 1.330 |
Why?
| | Swine | 18 | 2017 | 775 | 1.270 |
Why?
| | Collagen | 8 | 2025 | 452 | 1.220 |
Why?
| | Immobilized Proteins | 3 | 2016 | 10 | 1.200 |
Why?
| | Myofibroblasts | 3 | 2017 | 127 | 1.160 |
Why?
| | Cell Movement | 11 | 2019 | 967 | 1.120 |
Why?
| | Cell Adhesion | 15 | 2025 | 466 | 1.120 |
Why?
| | Endothelial Cells | 5 | 2017 | 785 | 1.020 |
Why?
| | Heart Valves | 5 | 2010 | 43 | 0.990 |
Why?
| | Cell Proliferation | 15 | 2017 | 2475 | 0.960 |
Why?
| | Cells, Cultured | 21 | 2022 | 4193 | 0.960 |
Why?
| | Wound Healing | 6 | 2016 | 331 | 0.860 |
Why?
| | Fibroblasts | 8 | 2013 | 996 | 0.820 |
Why?
| | Fibronectins | 5 | 2021 | 133 | 0.730 |
Why?
| | Gelatin | 3 | 2025 | 52 | 0.720 |
Why?
| | Osteoblasts | 2 | 2012 | 126 | 0.700 |
Why?
| | Simvastatin | 2 | 2012 | 61 | 0.680 |
Why?
| | Surface Properties | 11 | 2013 | 413 | 0.630 |
Why?
| | Animals | 36 | 2021 | 36940 | 0.620 |
Why?
| | Laminin | 3 | 2015 | 72 | 0.600 |
Why?
| | Gene Expression Regulation | 7 | 2017 | 2607 | 0.590 |
Why?
| | Fibrosis | 2 | 2022 | 552 | 0.570 |
Why?
| | Contracts | 1 | 2017 | 12 | 0.560 |
Why?
| | Cell Communication | 4 | 2018 | 315 | 0.560 |
Why?
| | Mentors | 2 | 2017 | 202 | 0.550 |
Why?
| | NIH 3T3 Cells | 9 | 2014 | 144 | 0.550 |
Why?
| | Phospholipase C gamma | 2 | 2019 | 29 | 0.540 |
Why?
| | Science | 1 | 2017 | 53 | 0.520 |
Why?
| | Methacrylates | 1 | 2017 | 117 | 0.520 |
Why?
| | Actins | 4 | 2012 | 416 | 0.500 |
Why?
| | Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2012 | 445 | 0.500 |
Why?
| | Signal Transduction | 5 | 2018 | 5079 | 0.490 |
Why?
| | Documentation | 1 | 2017 | 194 | 0.480 |
Why?
| | Hyperlipoproteinemia Type II | 1 | 2015 | 35 | 0.470 |
Why?
| | Muscle Proteins | 1 | 2017 | 231 | 0.470 |
Why?
| | Atherosclerosis | 1 | 2019 | 415 | 0.470 |
Why?
| | Tissue Scaffolds | 4 | 2021 | 211 | 0.470 |
Why?
| | Osteocalcin | 2 | 2012 | 37 | 0.460 |
Why?
| | Interprofessional Relations | 1 | 2017 | 283 | 0.460 |
Why?
| | Polymers | 6 | 2015 | 490 | 0.460 |
Why?
| | Pluripotent Stem Cells | 1 | 2015 | 80 | 0.440 |
Why?
| | Intercellular Signaling Peptides and Proteins | 2 | 2018 | 382 | 0.430 |
Why?
| | Nitric Oxide Donors | 2 | 2005 | 21 | 0.430 |
Why?
| | Intracranial Aneurysm | 1 | 2014 | 97 | 0.410 |
Why?
| | Materials Testing | 6 | 2017 | 356 | 0.400 |
Why?
| | Ovarian Neoplasms | 3 | 2025 | 565 | 0.390 |
Why?
| | Communication | 2 | 2023 | 879 | 0.390 |
Why?
| | Extracellular Matrix Proteins | 2 | 2014 | 153 | 0.390 |
Why?
| | Molecular Structure | 8 | 2014 | 489 | 0.390 |
Why?
| | Apoptosis | 8 | 2017 | 2553 | 0.390 |
Why?
| | RNA | 2 | 2017 | 921 | 0.380 |
Why?
| | Computer Simulation | 2 | 2018 | 978 | 0.380 |
Why?
| | Adsorption | 4 | 2013 | 149 | 0.380 |
Why?
| | Cell Differentiation | 9 | 2018 | 1991 | 0.380 |
Why?
| | Embolization, Therapeutic | 1 | 2014 | 229 | 0.370 |
Why?
| | Fallopian Tubes | 2 | 2022 | 31 | 0.370 |
Why?
| | Dermatan Sulfate | 1 | 2010 | 4 | 0.350 |
Why?
| | Macrophages | 3 | 2015 | 1547 | 0.350 |
Why?
| | Biofouling | 1 | 2010 | 8 | 0.350 |
Why?
| | Cystadenocarcinoma, Serous | 2 | 2022 | 77 | 0.350 |
Why?
| | Peptides | 4 | 2014 | 985 | 0.340 |
Why?
| | rho GTP-Binding Proteins | 1 | 2010 | 60 | 0.330 |
Why?
| | Gene Regulatory Networks | 1 | 2012 | 305 | 0.320 |
Why?
| | Candida albicans | 3 | 2015 | 54 | 0.320 |
Why?
| | Tissue Culture Techniques | 3 | 2017 | 78 | 0.320 |
Why?
| | Gene Expression | 2 | 2012 | 1502 | 0.320 |
Why?
| | Integrins | 1 | 2010 | 95 | 0.320 |
Why?
| | Algorithms | 1 | 2017 | 1704 | 0.320 |
Why?
| | Phenotype | 7 | 2021 | 3196 | 0.320 |
Why?
| | Hydrogels | 7 | 2019 | 678 | 0.320 |
Why?
| | Adipogenesis | 1 | 2009 | 55 | 0.310 |
Why?
| | Regeneration | 1 | 2011 | 197 | 0.310 |
Why?
| | Biomimetic Materials | 1 | 2009 | 72 | 0.300 |
Why?
| | Research Personnel | 2 | 2021 | 173 | 0.300 |
Why?
| | Biomarkers | 7 | 2021 | 4149 | 0.300 |
Why?
| | Stem Cells | 2 | 2011 | 594 | 0.300 |
Why?
| | Flow Cytometry | 3 | 2021 | 1178 | 0.300 |
Why?
| | Mitogen-Activated Protein Kinase 3 | 1 | 2009 | 152 | 0.290 |
Why?
| | Cell Line | 5 | 2017 | 2847 | 0.290 |
Why?
| | Mitogen-Activated Protein Kinase 1 | 1 | 2009 | 185 | 0.290 |
Why?
| | Adipocytes | 1 | 2009 | 222 | 0.280 |
Why?
| | Transforming Growth Factor beta1 | 1 | 2008 | 165 | 0.280 |
Why?
| | Humans | 33 | 2025 | 137585 | 0.270 |
Why?
| | MAP Kinase Signaling System | 1 | 2009 | 320 | 0.260 |
Why?
| | Heart Valve Prosthesis | 2 | 2005 | 114 | 0.260 |
Why?
| | Insulin-Like Growth Factor I | 1 | 2008 | 319 | 0.250 |
Why?
| | Amino Acids | 1 | 2009 | 497 | 0.250 |
Why?
| | Mice | 13 | 2020 | 17787 | 0.240 |
Why?
| | Molecular Weight | 3 | 2013 | 335 | 0.240 |
Why?
| | Cell Survival | 5 | 2017 | 1120 | 0.240 |
Why?
| | S-Nitrosothiols | 1 | 2005 | 5 | 0.230 |
Why?
| | Bioprosthesis | 1 | 2005 | 40 | 0.230 |
Why?
| | Tunica Intima | 1 | 2005 | 84 | 0.230 |
Why?
| | Antifungal Agents | 3 | 2015 | 136 | 0.230 |
Why?
| | Biomedical Engineering | 2 | 2018 | 27 | 0.220 |
Why?
| | Cysteine | 1 | 2005 | 204 | 0.210 |
Why?
| | Mass Behavior | 1 | 2023 | 3 | 0.210 |
Why?
| | Gelatinases | 1 | 2022 | 6 | 0.200 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 3 | 2017 | 852 | 0.200 |
Why?
| | Time Factors | 5 | 2015 | 6828 | 0.190 |
Why?
| | Ligands | 2 | 2018 | 664 | 0.190 |
Why?
| | Culture Media, Serum-Free | 3 | 2012 | 48 | 0.190 |
Why?
| | Fallopian Tube Neoplasms | 1 | 2022 | 17 | 0.190 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 2 | 2017 | 976 | 0.190 |
Why?
| | Matrix Metalloproteinases | 1 | 2022 | 95 | 0.190 |
Why?
| | Carcinoma in Situ | 1 | 2022 | 49 | 0.180 |
Why?
| | Bacterial Adhesion | 2 | 2013 | 100 | 0.180 |
Why?
| | Pressure Ulcer | 1 | 2022 | 46 | 0.180 |
Why?
| | Staining and Labeling | 1 | 2022 | 150 | 0.180 |
Why?
| | Cytokines | 3 | 2021 | 2085 | 0.180 |
Why?
| | Monitoring, Immunologic | 1 | 2021 | 25 | 0.180 |
Why?
| | Dose-Response Relationship, Drug | 6 | 2014 | 2057 | 0.170 |
Why?
| | Diabetes Mellitus, Experimental | 1 | 2002 | 195 | 0.170 |
Why?
| | Financial Management | 1 | 2021 | 18 | 0.170 |
Why?
| | Hydrogel, Polyethylene Glycol Dimethacrylate | 3 | 2009 | 77 | 0.170 |
Why?
| | Cell Count | 2 | 2013 | 324 | 0.170 |
Why?
| | Women | 1 | 2020 | 50 | 0.170 |
Why?
| | Culture Media | 2 | 2017 | 165 | 0.160 |
Why?
| | Cattle | 3 | 2013 | 984 | 0.160 |
Why?
| | Azides | 2 | 2011 | 46 | 0.160 |
Why?
| | Immunohistochemistry | 2 | 2017 | 1738 | 0.160 |
Why?
| | Immunophenotyping | 1 | 2021 | 318 | 0.160 |
Why?
| | Oropharyngeal Neoplasms | 1 | 2020 | 63 | 0.160 |
Why?
| | Nitric Oxide | 1 | 2005 | 915 | 0.160 |
Why?
| | Nasal Mucosa | 1 | 2020 | 107 | 0.160 |
Why?
| | Papillomaviridae | 1 | 2020 | 125 | 0.160 |
Why?
| | rho-Associated Kinases | 2 | 2010 | 83 | 0.150 |
Why?
| | Solubility | 2 | 2010 | 245 | 0.150 |
Why?
| | Microfluidics | 2 | 2018 | 54 | 0.150 |
Why?
| | Nurses | 1 | 2022 | 180 | 0.150 |
Why?
| | Workload | 1 | 2020 | 167 | 0.150 |
Why?
| | Shock, Septic | 1 | 2021 | 219 | 0.150 |
Why?
| | Microfilament Proteins | 1 | 2019 | 133 | 0.150 |
Why?
| | Platelet Adhesiveness | 2 | 2010 | 15 | 0.150 |
Why?
| | Leukocytes, Mononuclear | 1 | 2021 | 558 | 0.140 |
Why?
| | Antigens, CD | 1 | 2021 | 521 | 0.140 |
Why?
| | Disease Models, Animal | 3 | 2020 | 4295 | 0.140 |
Why?
| | Cations | 2 | 2014 | 84 | 0.140 |
Why?
| | Skin | 1 | 2002 | 752 | 0.140 |
Why?
| | Interferon-gamma | 1 | 2021 | 789 | 0.140 |
Why?
| | Biomedical Research | 2 | 2021 | 692 | 0.140 |
Why?
| | Glycosaminoglycans | 1 | 2017 | 83 | 0.140 |
Why?
| | Lipoproteins, LDL | 1 | 2017 | 116 | 0.140 |
Why?
| | Lipopolysaccharides | 1 | 2021 | 886 | 0.140 |
Why?
| | Cell Line, Tumor | 3 | 2025 | 3412 | 0.130 |
Why?
| | Sex Characteristics | 1 | 2022 | 762 | 0.130 |
Why?
| | Proteins | 2 | 2013 | 1009 | 0.130 |
Why?
| | Elastic Modulus | 1 | 2017 | 123 | 0.130 |
Why?
| | Pressure | 1 | 2018 | 225 | 0.130 |
Why?
| | Least-Squares Analysis | 2 | 2016 | 79 | 0.130 |
Why?
| | DNA | 3 | 2013 | 1459 | 0.120 |
Why?
| | Papillomavirus Infections | 1 | 2020 | 325 | 0.120 |
Why?
| | Molecular Probes | 1 | 2016 | 36 | 0.120 |
Why?
| | Cross-Linking Reagents | 2 | 2008 | 217 | 0.120 |
Why?
| | Mitogen-Activated Protein Kinase Kinases | 1 | 2016 | 134 | 0.120 |
Why?
| | Light | 3 | 2010 | 381 | 0.120 |
Why?
| | Cholesterol, LDL | 1 | 2017 | 365 | 0.120 |
Why?
| | Female | 9 | 2025 | 73304 | 0.120 |
Why?
| | Cellular Microenvironment | 1 | 2016 | 84 | 0.120 |
Why?
| | Recombinant Proteins | 2 | 2009 | 1353 | 0.120 |
Why?
| | Embryoid Bodies | 1 | 2014 | 8 | 0.120 |
Why?
| | Plaque, Atherosclerotic | 1 | 2015 | 57 | 0.110 |
Why?
| | Bacillus cereus | 1 | 2014 | 5 | 0.110 |
Why?
| | Drug Resistance, Fungal | 1 | 2014 | 7 | 0.110 |
Why?
| | Cerebral Angiography | 1 | 2014 | 109 | 0.110 |
Why?
| | Antigens | 2 | 2006 | 357 | 0.110 |
Why?
| | Biomechanical Phenomena | 1 | 2017 | 810 | 0.110 |
Why?
| | DNA Replication | 2 | 2014 | 238 | 0.110 |
Why?
| | Antibodies | 2 | 2006 | 410 | 0.110 |
Why?
| | Embryonic Stem Cells | 1 | 2014 | 129 | 0.100 |
Why?
| | Erythrocytes | 2 | 2010 | 700 | 0.100 |
Why?
| | Cholesterol | 1 | 2015 | 410 | 0.100 |
Why?
| | Acrylates | 2 | 2011 | 47 | 0.100 |
Why?
| | Gene Transfer Techniques | 1 | 2014 | 170 | 0.100 |
Why?
| | Stress, Mechanical | 3 | 2010 | 485 | 0.100 |
Why?
| | Salmonella enterica | 1 | 2014 | 57 | 0.100 |
Why?
| | U937 Cells | 1 | 2013 | 24 | 0.100 |
Why?
| | Anti-Bacterial Agents | 2 | 2014 | 1809 | 0.100 |
Why?
| | Tumor Microenvironment | 1 | 2017 | 674 | 0.100 |
Why?
| | Dogs | 1 | 2014 | 413 | 0.100 |
Why?
| | Vitronectin | 1 | 2012 | 9 | 0.100 |
Why?
| | Transfection | 1 | 2014 | 945 | 0.100 |
Why?
| | Mechanical Phenomena | 1 | 2013 | 84 | 0.100 |
Why?
| | RNA, Small Interfering | 1 | 2014 | 622 | 0.100 |
Why?
| | ErbB Receptors | 2 | 2019 | 614 | 0.100 |
Why?
| | Biofilms | 1 | 2015 | 260 | 0.100 |
Why?
| | beta-Lactams | 1 | 2012 | 33 | 0.090 |
Why?
| | Pandemics | 1 | 2020 | 1639 | 0.090 |
Why?
| | Alkaline Phosphatase | 1 | 2012 | 148 | 0.090 |
Why?
| | Oxidation-Reduction | 1 | 2015 | 1060 | 0.090 |
Why?
| | Hemodynamics | 1 | 2017 | 1113 | 0.090 |
Why?
| | Primary Cell Culture | 1 | 2012 | 171 | 0.090 |
Why?
| | Models, Biological | 2 | 2016 | 1783 | 0.090 |
Why?
| | Microscopy, Fluorescence | 2 | 2010 | 402 | 0.090 |
Why?
| | Carbodiimides | 1 | 2011 | 4 | 0.090 |
Why?
| | Genetic Markers | 1 | 2012 | 344 | 0.090 |
Why?
| | Pseudomonas aeruginosa | 1 | 2014 | 352 | 0.090 |
Why?
| | Dermis | 1 | 2011 | 33 | 0.090 |
Why?
| | Amines | 1 | 2011 | 40 | 0.090 |
Why?
| | Stimulation, Chemical | 1 | 2010 | 59 | 0.090 |
Why?
| | Aging | 1 | 2021 | 1864 | 0.090 |
Why?
| | Chromatography, Gel | 1 | 2010 | 127 | 0.090 |
Why?
| | Osteogenesis | 1 | 2012 | 188 | 0.090 |
Why?
| | Receptors, Laminin | 1 | 2010 | 1 | 0.090 |
Why?
| | Glycols | 1 | 2010 | 7 | 0.090 |
Why?
| | Integrin alpha5beta1 | 1 | 2010 | 9 | 0.080 |
Why?
| | Hyaluronan Receptors | 1 | 2010 | 102 | 0.080 |
Why?
| | Blood Proteins | 1 | 2012 | 252 | 0.080 |
Why?
| | Oligonucleotide Array Sequence Analysis | 1 | 2012 | 767 | 0.080 |
Why?
| | Adhesiveness | 1 | 2009 | 20 | 0.080 |
Why?
| | Neovascularization, Physiologic | 1 | 2011 | 179 | 0.080 |
Why?
| | Microfluidic Analytical Techniques | 1 | 2010 | 77 | 0.080 |
Why?
| | Extracellular Signal-Regulated MAP Kinases | 1 | 2010 | 171 | 0.080 |
Why?
| | Butadienes | 1 | 2009 | 36 | 0.080 |
Why?
| | MAP Kinase Kinase 2 | 1 | 2009 | 28 | 0.080 |
Why?
| | Polyethylene Glycols | 3 | 2009 | 641 | 0.080 |
Why?
| | Cell Separation | 1 | 2010 | 318 | 0.080 |
Why?
| | Mechanotransduction, Cellular | 1 | 2010 | 111 | 0.080 |
Why?
| | Oligosaccharides | 1 | 2009 | 60 | 0.080 |
Why?
| | Mevalonic Acid | 1 | 2008 | 13 | 0.080 |
Why?
| | MAP Kinase Kinase 1 | 1 | 2009 | 75 | 0.080 |
Why?
| | Succinimides | 1 | 2008 | 19 | 0.080 |
Why?
| | Rhodamines | 1 | 2008 | 20 | 0.070 |
Why?
| | Polystyrenes | 1 | 2008 | 35 | 0.070 |
Why?
| | JNK Mitogen-Activated Protein Kinases | 1 | 2009 | 162 | 0.070 |
Why?
| | Flavonoids | 1 | 2009 | 85 | 0.070 |
Why?
| | Gels | 1 | 2008 | 80 | 0.070 |
Why?
| | Cell Line, Transformed | 1 | 2008 | 145 | 0.070 |
Why?
| | Thermodynamics | 1 | 2010 | 407 | 0.070 |
Why?
| | Male | 4 | 2022 | 67762 | 0.070 |
Why?
| | Structure-Activity Relationship | 3 | 2014 | 570 | 0.070 |
Why?
| | Bone and Bones | 1 | 2011 | 317 | 0.070 |
Why?
| | Nitriles | 1 | 2009 | 172 | 0.070 |
Why?
| | Microbial Sensitivity Tests | 3 | 2014 | 361 | 0.070 |
Why?
| | Fibrin | 1 | 2008 | 81 | 0.070 |
Why?
| | Age Factors | 1 | 2015 | 3295 | 0.070 |
Why?
| | Neoplasms | 1 | 2023 | 2671 | 0.070 |
Why?
| | Disease Progression | 1 | 2015 | 2757 | 0.070 |
Why?
| | Proto-Oncogene Proteins c-akt | 1 | 2010 | 437 | 0.070 |
Why?
| | Drug Synergism | 1 | 2008 | 382 | 0.070 |
Why?
| | Spectroscopy, Fourier Transform Infrared | 1 | 2007 | 86 | 0.070 |
Why?
| | Reproducibility of Results | 2 | 2022 | 3284 | 0.070 |
Why?
| | Breast Neoplasms | 1 | 2019 | 2253 | 0.070 |
Why?
| | Fluorescent Dyes | 1 | 2008 | 321 | 0.070 |
Why?
| | Bacteria | 1 | 2013 | 858 | 0.060 |
Why?
| | Sex Factors | 1 | 2012 | 2071 | 0.060 |
Why?
| | Curriculum | 1 | 2012 | 992 | 0.060 |
Why?
| | Enzyme Inhibitors | 1 | 2009 | 840 | 0.060 |
Why?
| | Phosphorylation | 1 | 2010 | 1759 | 0.060 |
Why?
| | Indoles | 1 | 2008 | 412 | 0.060 |
Why?
| | Elastin | 1 | 2005 | 78 | 0.060 |
Why?
| | Gene Expression Profiling | 1 | 2012 | 1774 | 0.060 |
Why?
| | Compressive Strength | 1 | 2005 | 74 | 0.060 |
Why?
| | Protein Engineering | 1 | 2005 | 97 | 0.060 |
Why?
| | Cyclic GMP | 1 | 2005 | 93 | 0.060 |
Why?
| | Stress Fibers | 1 | 2004 | 19 | 0.060 |
Why?
| | Elasticity | 1 | 2005 | 197 | 0.060 |
Why?
| | Angioplasty, Balloon, Coronary | 1 | 2005 | 141 | 0.050 |
Why?
| | Calcium | 1 | 2010 | 1199 | 0.050 |
Why?
| | Blood Platelets | 1 | 2007 | 408 | 0.050 |
Why?
| | Hydrophobic and Hydrophilic Interactions | 2 | 2014 | 187 | 0.050 |
Why?
| | Genetic Predisposition to Disease | 1 | 2012 | 2426 | 0.050 |
Why?
| | Carotid Arteries | 1 | 2005 | 206 | 0.050 |
Why?
| | Polyvinyl Alcohol | 1 | 2002 | 18 | 0.050 |
Why?
| | Myocytes, Smooth Muscle | 1 | 2005 | 261 | 0.050 |
Why?
| | Occlusive Dressings | 1 | 2002 | 5 | 0.050 |
Why?
| | Polyvinyl Chloride | 1 | 2002 | 9 | 0.050 |
Why?
| | Neoplasm Metastasis | 1 | 2025 | 658 | 0.050 |
Why?
| | Versicans | 1 | 2021 | 5 | 0.050 |
Why?
| | Cicatrix | 1 | 2002 | 64 | 0.050 |
Why?
| | Meta-Analysis as Topic | 1 | 2021 | 186 | 0.040 |
Why?
| | In Vitro Techniques | 1 | 2002 | 1092 | 0.040 |
Why?
| | National Institutes of Health (U.S.) | 1 | 2021 | 128 | 0.040 |
Why?
| | HLA-DR Antigens | 1 | 2021 | 228 | 0.040 |
Why?
| | Oropharynx | 1 | 2020 | 46 | 0.040 |
Why?
| | Workflow | 1 | 2021 | 165 | 0.040 |
Why?
| | Rats, Sprague-Dawley | 1 | 2005 | 2486 | 0.040 |
Why?
| | Rats | 2 | 2005 | 5647 | 0.040 |
Why?
| | Spheroids, Cellular | 1 | 2019 | 76 | 0.040 |
Why?
| | Peer Group | 1 | 2020 | 242 | 0.040 |
Why?
| | Gene Knockdown Techniques | 1 | 2019 | 327 | 0.040 |
Why?
| | Neoplasm Invasiveness | 1 | 2019 | 510 | 0.030 |
Why?
| | Endoscopy | 1 | 2020 | 318 | 0.030 |
Why?
| | Transcriptional Activation | 1 | 2019 | 378 | 0.030 |
Why?
| | Anesthesia | 1 | 2020 | 189 | 0.030 |
Why?
| | Social Support | 1 | 2020 | 618 | 0.030 |
Why?
| | Biopsy | 1 | 2020 | 1129 | 0.030 |
Why?
| | Cell Aggregation | 1 | 2016 | 26 | 0.030 |
Why?
| | Predictive Value of Tests | 1 | 2021 | 2031 | 0.030 |
Why?
| | Photochemistry | 2 | 2006 | 134 | 0.030 |
Why?
| | Proteomics | 1 | 2021 | 1111 | 0.030 |
Why?
| | Mothers | 1 | 2020 | 754 | 0.030 |
Why?
| | Clinical Competence | 1 | 2022 | 1118 | 0.030 |
Why?
| | Models, Chemical | 2 | 2007 | 263 | 0.030 |
Why?
| | Regression Analysis | 1 | 2016 | 1024 | 0.030 |
Why?
| | Case-Control Studies | 1 | 2021 | 3556 | 0.030 |
Why?
| | 3T3 Cells | 1 | 2013 | 163 | 0.030 |
Why?
| | Caregivers | 1 | 2020 | 877 | 0.020 |
Why?
| | Molecular Conformation | 1 | 2013 | 145 | 0.020 |
Why?
| | Drug Evaluation, Preclinical | 1 | 2013 | 184 | 0.020 |
Why?
| | Behavior | 1 | 2012 | 90 | 0.020 |
Why?
| | Rheumatic Heart Disease | 1 | 2011 | 7 | 0.020 |
Why?
| | Awareness | 1 | 2012 | 103 | 0.020 |
Why?
| | Cell Division | 2 | 2004 | 794 | 0.020 |
Why?
| | Mice, Inbred C57BL | 1 | 2002 | 5757 | 0.020 |
Why?
| | Hemolysis | 1 | 2013 | 206 | 0.020 |
Why?
| | National Heart, Lung, and Blood Institute (U.S.) | 1 | 2011 | 104 | 0.020 |
Why?
| | Personal Satisfaction | 1 | 2012 | 207 | 0.020 |
Why?
| | Cross-Sectional Studies | 1 | 2022 | 5472 | 0.020 |
Why?
| | Cell Size | 1 | 2010 | 91 | 0.020 |
Why?
| | Shear Strength | 1 | 2010 | 67 | 0.020 |
Why?
| | Tensile Strength | 1 | 2010 | 97 | 0.020 |
Why?
| | Equipment Failure Analysis | 1 | 2010 | 132 | 0.020 |
Why?
| | United States | 2 | 2021 | 14841 | 0.020 |
Why?
| | Prospective Studies | 1 | 2022 | 7604 | 0.020 |
Why?
| | Learning | 1 | 2012 | 409 | 0.020 |
Why?
| | Equipment Design | 1 | 2010 | 522 | 0.020 |
Why?
| | Fluoresceins | 1 | 2007 | 47 | 0.020 |
Why?
| | Antigen-Antibody Reactions | 1 | 2006 | 55 | 0.020 |
Why?
| | Tetrazolium Salts | 1 | 2005 | 17 | 0.020 |
Why?
| | Thiazoles | 1 | 2005 | 123 | 0.010 |
Why?
| | Glucagon | 1 | 2005 | 109 | 0.010 |
Why?
| | Microscopy, Confocal | 1 | 2005 | 325 | 0.010 |
Why?
| | Microscopy, Phase-Contrast | 1 | 2002 | 18 | 0.010 |
Why?
| | Hydroxyproline | 1 | 2002 | 21 | 0.010 |
Why?
| | Kinetics | 1 | 2005 | 1670 | 0.010 |
Why?
| | Sensitivity and Specificity | 1 | 2006 | 1946 | 0.010 |
Why?
| | Promoter Regions, Genetic | 1 | 2004 | 1250 | 0.010 |
Why?
|
|
Masters's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|